Phosphodiesterase 4 Inhibitors in Inflammatory Bowel Disease: A Comprehensive Review

E-ISSN： 1873-4286|16|33|3661-3667

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.33, 2010-11, pp. : 3661-3667

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterase inhibitors in inflammatory bowel disease

By Salari Pooneh Abdollahi Mohammad

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 3, 2012-03 ,pp. : 261-264

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase-4 Inhibitors in the Treatment of Inflammatory Lung Disease

By Spina D.

Drugs, Vol. 63, Iss. 23, 2003-01 ,pp. : 2575-2594

Adis International

Access to resources Recommend Favorite

Melatonin, a Promising Supplement in Inflammatory Bowel Disease: A Comprehensive Review of Evidences

Current Pharmaceutical Design, Vol. 17, Iss. 38, 2011-12 ,pp. : 4372-4378

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?

By Teixeira M.M. Gristwood R.W. Cooper N. Hellewell P.G.

Trends in Pharmacological Sciences, Vol. 18, Iss. 5, 1997-05 ,pp. : 164-170

Elsevier

Access to resources Recommend Favorite

Phosphodiesterase 4 inhibitors

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 4, 1997-04 ,pp. : 385-387

Informa Healthcare

Access to resources Recommend Favorite